Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.
Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.